Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.49
-1.50 (-5.17%)
At close: Nov 20, 2024, 4:00 PM
27.74
+0.25 (0.91%)
After-hours: Nov 20, 2024, 7:09 PM EST
Apellis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for APLS stock have an average target of 51, with a low estimate of 24 and a high estimate of 106. The average target predicts an increase of 85.52% from the current stock price of 27.49.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for APLS stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 4 | 4 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 15 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $92 → $55 | Buy | Maintains | $92 → $55 | +100.07% | Nov 7, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $63 → $51 | Strong Buy | Maintains | $63 → $51 | +85.52% | Nov 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $71 → $36 | Strong Buy | Maintains | $71 → $36 | +30.96% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | -12.70% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $35 → $30 | Hold | Maintains | $35 → $30 | +9.13% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
775.68M
from 396.59M
Increased by 95.59%
Revenue Next Year
882.51M
from 775.68M
Increased by 13.77%
EPS This Year
-1.71
from -4.45
EPS Next Year
-0.86
from -1.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 814.6M | 1.1B | 2.2B | ||
| Avg | 775.7M | 882.5M | 1.1B | ||
| Low | 725.0M | 757.9M | 872.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.4% | 36.1% | 145.2% | ||
| Avg | 95.6% | 13.8% | 28.4% | ||
| Low | 82.8% | -2.3% | -1.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.41 | 0.08 | 7.06 | ||
| Avg | -1.71 | -0.86 | 1.18 | ||
| Low | -1.96 | -1.70 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.